Does the 5–2-1 criteria identify patients with advanced Parkinson's disease? Real-world screening accuracy and burden of 5–2-1-positive patients in 7 countries

BACKGROUND: The burden of Parkinson’s disease (PD) worsens with disease progression. However, the lack of objective and uniform disease classification challenges our understanding of the incremental burden in patients with advanced Parkinson’s disease (APD) and suboptimal medication control. The 5–2...

Descripción completa

Detalles Bibliográficos
Autores principales: Malaty, Irene A., Martinez-Martin, Pablo, Chaudhuri, K. Ray, Odin, Per, Skorvanek, Matej, Jimenez-Shahed, Joohi, Soileau, Michael J., Lindvall, Susanna, Domingos, Josefa, Jones, Sarah, Alobaidi, Ali, Jalundhwala, Yash J., Kandukuri, Prasanna L., Onuk, Koray, Bergmann, Lars, Femia, Samira, Lee, Michelle Y., Wright, Jack, Antonini, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785442/
https://www.ncbi.nlm.nih.gov/pubmed/35073872
http://dx.doi.org/10.1186/s12883-022-02560-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8785442/
https://www.ncbi.nlm.nih.gov/pubmed/35073872
http://dx.doi.org/10.1186/s12883-022-02560-1

Ejemplares similares